Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luisa Guidi

Showing results (31-40 of 64) with videos related to

Pageof 7
Sort By:
Journal of Gastrointestinal and Liver Diseases : JGLD|March 30, 2013
Comparison of Quantiferon-TB Gold versus tuberculin skin test for tuberculosis screening in inflammatory bowel disease patientsGianluca Andrisani, Alessandro Armuzzi, Alfredo Papa, et al.
Rays|April 17, 2003
Small bowel diseasesItalo De Vitis, Cristiano Spada, Giuseppe Alessandro Pirozzi, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|June 8, 2020
TRPM7 is overexpressed in human IBD-related and sporadic colorectal cancer and correlates with tumor gradeDaniela Pugliese, Alessandro Armuzzi, Federica Castri, et al.
Journal of Crohn'S & Colitis|July 2, 2013
Prevention of postoperative recurrence with azathioprine or infliximab in patients with Crohn's disease: an open-label pilot studyAlessandro Armuzzi, Carla Felice, Alfredo Papa, et al.
RMD Open|April 17, 2018
Paradoxical arthritis occurring during anti-TNF in patients with inflammatory bowel disease: histological and immunological features of a complex synovitisStefano Alivernini, Daniela Pugliese, Barbara Tolusso, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|August 7, 2014
Faecal calprotectin assay after induction with anti-Tumour Necrosis Factor α agents in inflammatory bowel disease: Prediction of clinical response and mucosal healing at one yearLuisa Guidi, Manuela Marzo, Gianluca Andrisani, et al.
Journal of Crohn'S & Colitis|April 3, 2012
Prevalence and natural history of hepatitis B and C infections in a large population of IBD patients treated with anti-tumor necrosis factor-α agentsAlfredo Papa, Carla Felice, Manuela Marzo, et al.
Inflammatory Bowel Diseases|March 2, 2013
Infliximab in steroid-dependent ulcerative colitis: effectiveness and predictors of clinical and endoscopic remissionAlessandro Armuzzi, Daniela Pugliese, Silvio Danese, et al.
European Journal of Immunology|March 15, 2011
Functional type 1 regulatory T cells develop regardless of FOXP3 mutations in patients with IPEX syndromeLaura Passerini, Sara Di Nunzio, Silvia Gregori, et al.
Oncotarget|October 27, 2015
Linking estrogen receptor β expression with inflammatory bowel disease activityMarina Pierdominici, Angela Maselli, Barbara Varano, et al.
Pageof 7

Showing results (31-40 of 64) with videos related to

Sort By:
Pageof 7
Journal of Gastrointestinal and Liver Diseases : JGLD|March 30, 2013
Comparison of Quantiferon-TB Gold versus tuberculin skin test for tuberculosis screening in inflammatory bowel disease patientsGianluca Andrisani, Alessandro Armuzzi, Alfredo Papa, et al.
Rays|April 17, 2003
Small bowel diseasesItalo De Vitis, Cristiano Spada, Giuseppe Alessandro Pirozzi, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|June 8, 2020
TRPM7 is overexpressed in human IBD-related and sporadic colorectal cancer and correlates with tumor gradeDaniela Pugliese, Alessandro Armuzzi, Federica Castri, et al.
Journal of Crohn'S & Colitis|July 2, 2013
Prevention of postoperative recurrence with azathioprine or infliximab in patients with Crohn's disease: an open-label pilot studyAlessandro Armuzzi, Carla Felice, Alfredo Papa, et al.
RMD Open|April 17, 2018
Paradoxical arthritis occurring during anti-TNF in patients with inflammatory bowel disease: histological and immunological features of a complex synovitisStefano Alivernini, Daniela Pugliese, Barbara Tolusso, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|August 7, 2014
Faecal calprotectin assay after induction with anti-Tumour Necrosis Factor α agents in inflammatory bowel disease: Prediction of clinical response and mucosal healing at one yearLuisa Guidi, Manuela Marzo, Gianluca Andrisani, et al.
Journal of Crohn'S & Colitis|April 3, 2012
Prevalence and natural history of hepatitis B and C infections in a large population of IBD patients treated with anti-tumor necrosis factor-α agentsAlfredo Papa, Carla Felice, Manuela Marzo, et al.
Inflammatory Bowel Diseases|March 2, 2013
Infliximab in steroid-dependent ulcerative colitis: effectiveness and predictors of clinical and endoscopic remissionAlessandro Armuzzi, Daniela Pugliese, Silvio Danese, et al.
European Journal of Immunology|March 15, 2011
Functional type 1 regulatory T cells develop regardless of FOXP3 mutations in patients with IPEX syndromeLaura Passerini, Sara Di Nunzio, Silvia Gregori, et al.
Oncotarget|October 27, 2015
Linking estrogen receptor β expression with inflammatory bowel disease activityMarina Pierdominici, Angela Maselli, Barbara Varano, et al.
Pageof 7